UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.
A cutting-edge platform developed by Assistant Professor Quanyin Hu uses protein-degrading platelets to suppress tumor regrowth and bolster immune response after surgery.
Professors Timothy Bugni, Lingjun Li, and Weiping Tang have received UW–Madison grants to advance their innovative multidisciplinary research.
Professor Weiping Tang creates a new type of molecule to tag proteins on the surface of cancer cells for degradation.
Alum Joe Su (PhD ’08) aims to tame the ‘Wild West’ of natural products to tackle chronic inflammation.
The School’s highest annual award celebrates alumni and friends for contributions to academia, community pharmacy, and pharmaceutical science.
Alumna Heidi Mansour (BS ‘96, PhD ’03), member of the National Academy of Inventors, aims to revolutionize lung and brain drug delivery.
Unique industry internships and special projects augment graduate student experience in the Psychoactive Pharmaceutical Investigation and Applied Drug Development programs.
Meet recent UW–Madison School of Pharmacy alumni who are leading their fields forward.
Through a National Institute of Justice grant, Assistant Professor Heather Barkholtz aims to tease out the toxicological difference between mirror-image meth isomers.